- MyIllumina
- Tools
The HumanOmni5-Quad (Omni5) BeadChip delivers the most comprehensive coverage of the genome, leveraging powerful tagSNPs selected from the International HapMap and 1000 Genomes Projects that target genetic variation down to 1% minor allele frequency (MAF). Omni5 provides the flexibility to add up to 500K custom markers, allowing researchers to tailor the BeadChip for targeted applications and population-specific studies. Using the proven HiScan™ or iScan systems, along with the Infinium® LCG Assay, this four-sample BeadChip offers high-throughput sample processing, and optimized content for whole-genome genotyping and CNV applications.
View the product support page for additional technical information »
View the Omni Family of Microarrays »
Catalog IDs: WG-311-5001, WG-311-5002, WG-311-5003, WG-311-5004
Product Literature
| HumanOmni5-Quad Data Sheet |
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.